Metraipolis › archive › dc_a2b9cfbdfec0

[Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm… — Europe PMC PMID:41407457

Source
Europe PMC (chi)
Original
https://europepmc.org/article/MED/41407457
DOI
10.3760/cma.j.cn121090-20250123-00043
License (as archived)
solo-consultazione
Archived
2026-11-08T20:44:11.225Z
SHA-256 of the archived text
3a7aa55fbce3f7acef5e9cb95fc249967a0db49edea76edc5e9164b1ef305ea1
Stable URL of this page
https://metraipolis.com/documento/dc_a2b9cfbdfec0

How to cite

[Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm… — Europe PMC PMID:41407457 — Europe PMC (chi), https://europepmc.org/article/MED/41407457 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a2b9cfbdfec0 (Metraipolis archive dc_a2b9cfbdfec0, sha256 3a7aa55fbce3f7acef5e9cb95fc249967a0db49edea76edc5e9164b1ef305ea1)
BibTeX
@misc{dca2b9cfbdfec0,
  title = {[Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm… — Europe PMC PMID:41407457},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/41407457},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a2b9cfbdfec0; sha256 3a7aa55fbce3f7acef5e9cb95fc249967a0db49edea76edc5e9164b1ef305ea1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41407457. Agents can read the archived copy with the MCP tool read_document.